Literature DB >> 26957610

Somatostatin Analogues in Neuroendocrine Tumors.

Matthew H Kulke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26957610     DOI: 10.6004/jnccn.2016.0029

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  2 in total

1.  Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors.

Authors:  Rajeev Ayyagari; Maureen Neary; Shang Li; Ariel Rokito; Hongbo Yang; Jipan Xie; Al B Benson
Journal:  Am Health Drug Benefits       Date:  2017-11

2.  Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study.

Authors:  Daniel M Halperin; Lynn Huynh; Jennifer L Beaumont; Beilei Cai; Todor Totev; Rachel H Bhak; Mei S Duh; Maureen P Neary; David Cella
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.